Stephen Chia

4.7k total citations
16 papers, 662 citations indexed

About

Stephen Chia is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephen Chia has authored 16 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephen Chia's work include Advanced Breast Cancer Therapies (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). Stephen Chia is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). Stephen Chia collaborates with scholars based in Canada, United States and Italy. Stephen Chia's co-authors include Sandra M. Swain, David R. Byrd, David A. Mankoff, Daniel J. Renouf, Paul C. McDonald, Zaihui Zhang, Madhu Singh, Quincy Chu, Philippe L. Bédard and Shoukat Dedhar and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gynecologic Oncology.

In The Last Decade

Stephen Chia

15 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Chia Canada 9 300 218 198 123 89 16 662
Rami Rahal Canada 15 391 1.3× 381 1.7× 82 0.4× 46 0.4× 46 0.5× 44 939
Tsion Z. Minas United States 16 310 1.0× 200 0.9× 125 0.6× 24 0.2× 30 0.3× 27 645
R. Theriault United States 13 264 0.9× 970 4.4× 439 2.2× 53 0.4× 166 1.9× 25 1.3k
Thomas Budd United States 12 127 0.4× 176 0.8× 109 0.6× 20 0.2× 46 0.5× 21 591
Catriona Parker United Kingdom 13 316 1.1× 234 1.1× 151 0.8× 64 0.5× 33 0.4× 28 852
Andrea Piga Italy 19 207 0.7× 258 1.2× 121 0.6× 21 0.2× 166 1.9× 35 792
Astrid Bosma Netherlands 16 625 2.1× 440 2.0× 224 1.1× 20 0.2× 75 0.8× 38 1.2k
J.-M. Nabholtz Canada 9 187 0.6× 518 2.4× 209 1.1× 54 0.4× 23 0.3× 24 742
Philip E. Lammers United States 18 198 0.7× 374 1.7× 116 0.6× 16 0.1× 71 0.8× 40 743
Kristen M. O’Dwyer United States 13 928 3.1× 358 1.6× 376 1.9× 71 0.6× 59 0.7× 51 1.6k

Countries citing papers authored by Stephen Chia

Since Specialization
Citations

This map shows the geographic impact of Stephen Chia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Chia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Chia more than expected).

Fields of papers citing papers by Stephen Chia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Chia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Chia. The network helps show where Stephen Chia may publish in the future.

Co-authorship network of co-authors of Stephen Chia

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Chia. A scholar is included among the top collaborators of Stephen Chia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Chia. Stephen Chia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brezden‐Masley, Christine, et al.. (2025). Clinician’s guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer. Therapeutic Advances in Medical Oncology. 17. 22771446–22771446.
2.
Janni, Wolfgang, Michael Untch, Nadia Harbeck, et al.. (2025). Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2− early breast cancer. The Breast. 81. 104429–104429. 3 indexed citations
3.
Rugo, Hope, Alessandra Gennari, Stephen Chia, et al.. (2024). Abstract PO2-04-10: Effect of Alpelisib Dose Modification for AE Management on Progression-Free Survival and Treatment Duration in SOLAR-1 and BYLieve Clinical Trials. Cancer Research. 84(9_Supplement). PO2–4. 1 indexed citations
4.
5.
6.
McDonald, Paul C., Stephen Chia, Philippe L. Bédard, et al.. (2020). A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors. American Journal of Clinical Oncology. 43(7). 484–490. 185 indexed citations
7.
Pataky, Reka, Linlea Armstrong, Stephen Chia, et al.. (2013). Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers. BMC Cancer. 13(1). 339–339. 40 indexed citations
8.
Teckle, Paulos, Helen McTaggart‐Cowan, Stephen Chia, et al.. (2013). Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health and Quality of Life Outcomes. 11(1). 203–203. 39 indexed citations
9.
Wu, Jonn, Cheryl Ho, Janessa Laskin, et al.. (2013). The Development of a Standardized Software Platform to Support Provincial Population-Based Cancer Outcomes Units for Multiple Tumour Sites: OaSIS - Outcomes and Surveillance Integration System. Studies in health technology and informatics. 183. 98–103. 2 indexed citations
10.
Teckle, Paulos, Stuart Peacock, Helen McTaggart‐Cowan, et al.. (2011). The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities. Health and Quality of Life Outcomes. 9(1). 106–106. 49 indexed citations
11.
Chlebowski, Rowan T., Jack Cuzick, Dereck D. Amakye, et al.. (2009). Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer. The Breast. 18. S1–S11. 36 indexed citations
12.
Seal, Melanie, Christine Wilson, Gregory J. Naus, et al.. (2009). Encapsulated apocrine papillary carcinoma of the breast—a tumour of uncertain malignant potential: report of five cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(6). 477–483. 23 indexed citations
13.
Chia, Stephen, Sandra M. Swain, David R. Byrd, & David A. Mankoff. (2008). Locally Advanced and Inflammatory Breast Cancer. Journal of Clinical Oncology. 26(5). 786–790. 126 indexed citations
14.
Tang, Patricia A., Lillian L. Siu, Eric X. Chen, et al.. (2007). Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck. Investigational New Drugs. 26(3). 257–264. 73 indexed citations
15.
Gelmon, Karen A., Karl Bélanger, Denis Soulières, et al.. (2005). A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC–CTG) IND 130. Investigational New Drugs. 23(5). 445–453. 5 indexed citations
16.
Brown, Lindsay, Julie Irving, Robin Parker, et al.. (2005). Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecologic Oncology. 100(2). 264–270. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rami Rahal Breakdown of academic impact, for papers by Tsion Z. Minas Breakdown of academic impact, for papers by R. Theriault Breakdown of academic impact, for papers by Thomas Budd Breakdown of academic impact, for papers by Catriona Parker Breakdown of academic impact, for papers by Andrea Piga Breakdown of academic impact, for papers by Astrid Bosma Breakdown of academic impact, for papers by J.-M. Nabholtz Breakdown of academic impact, for papers by Philip E. Lammers Breakdown of academic impact, for papers by Kristen M. O’Dwyer
Rankless by CCL
2026